Berberine and its more bioavailable derivative dihydroberberine inhibit mitochondrial complex I: a mechanism for the action of berberine to activate AMP activated protein kinase and improve insulin action
Diabetes, 2010
The 120 capsule format of Berberine HClโฏ500mg a full 60-day supply at the recommended dose of 2 capsules per day. Each vegan capsule delivers 500โฏmg of 97% pure berberine hydrochloride extracted fromย Berberis aristata root. BerberineโฏHCl activates AMPK (AMP activated protein kinase), the cellular energy sensor that governs glucose uptake, insulin sensitivity, hepatic glucose output, and fatty acid oxidation.
Berberine is an isoquinoline alkaloid from Berberis aristata (Indian barberry) root, with a clinical research profile spanning hundreds of human studies. Its primary mechanism is inhibition of mitochondrial complexโฏI, which raises the intracellular AMP to ATP ratio and triggers AMPK activation. AMPK coordinates: increased GLUT4-mediated glucose uptake in skeletal muscle; suppression of hepatic gluconeogenesis via PEPCK and G6Pase downregulation; inhibition of intestinal alpha glucosidase to blunt postprandial glucose rise; and selective modulation of gut microbiota to improve gut barrier integrity and insulin receptor expression.
The 120 capsule format of Berberine HClโฏ500mg a full 60-day supply at the recommended dose of 2 capsules per day. Each vegan capsule delivers 500โฏmg of 97% pure berberine hydrochloride extracted fromย Berberis aristata root. BerberineโฏHCl activates AMPK (AMP activated protein kinase), the cellular energy sensor that governs glucose uptake, insulin sensitivity, hepatic glucose output, and fatty acid oxidation.
Berberine is an isoquinoline alkaloid from Berberis aristata (Indian barberry) root, with a clinical research profile spanning hundreds of human studies. Its primary mechanism is inhibition of mitochondrial complexโฏI, which raises the intracellular AMP to ATP ratio and triggers AMPK activation. AMPK coordinates: increased GLUT4-mediated glucose uptake in skeletal muscle; suppression of hepatic gluconeogenesis via PEPCK and G6Pase downregulation; inhibition of intestinal alpha glucosidase to blunt postprandial glucose rise; and selective modulation of gut microbiota to improve gut barrier integrity and insulin receptor expression.
Serving Size: 1 Capsule
Servings Per Container: 120
โ Daily Value not established
Diabetes, 2010
Metabolism, 2008
Frontiers in Microbiology, 2020
Research information is provided for educational purposes and does not replace the product's approved label information.